Zacks Equity Research
UnitedHealth Group (UNH) ended the recent trading session at $372.80, demonstrating a -1.26% change from the preceding day's closing price. Elsewhere, the Dow saw a downswing of 0.36%, while the tech-heavy Nasdaq appreciated by 0.45%.
The stock of largest U.S. health insurer has fallen by 5.32% in the past month, lagging the Medical sector's loss of 3.65% and the S&P 500's gain of 1.27%.
UnitedHealth Group (UNH) ended the recent trading session at $372.80, demonstrating a -1.26% change from the preceding day's closing price. Elsewhere, the Dow saw a downswing of 0.36%, while the tech-heavy Nasdaq appreciated by 0.45%.
The stock of largest U.S. health insurer has fallen by 5.32% in the past month, lagging the Medical sector's loss of 3.65% and the S&P 500's gain of 1.27%.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 0.16% upward. Currently, UnitedHealth Group is carrying a Zacks Rank of #2 (Buy).
In terms of valuation, UnitedHealth Group is currently trading at a Forward P/E ratio of 19.02. This indicates a discount in contrast to its industry's Forward P/E of 23.21.
We can also see that UNH currently has a PEG ratio of 1.42. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. The average PEG ratio for the Medical - HMOs industry stood at 1.42 at the close of the market yesterday.
The Medical - HMOs industry is part of the Medical sector. With its current Zacks Industry Rank of 32, this industry ranks in the top 14% of all industries, numbering over 250.
No comments:
Post a Comment